Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 9Colorectal Neoplasms 7Ovarian Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Urogenital Neoplasms 2Neoplastic Syndromes, Hereditary 2Neoplasms, Unknown Primary 2Neoplasm Metastasis 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Hereditary Breast and Ovarian Cancer Syndrome 2Hematologic Neoplasms 2Glioma 2Carcinoma, Intraductal, Noninfiltrating 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Tuberous Sclerosis 1Thyroid Neoplasms 1Spinal Cord Neoplasms 1

Interventions

Practice Guidelines as Topic 8Standard of Care 7Specimen Handling 7Early Intervention, Educational 5pertuzumab 3Trastuzumab 3Methods 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Educational Status 3trastuzumab biosimilar HLX02 2Taxes 2Paclitaxel 2PF-05280014 2Ontruzant 2Ogivri 2Minoxidil 2Letrozole 2High-Energy Shock Waves 2Docetaxel 2Biopsy 2Acupuncture Therapy 22C4 antibody 2regadenoson 1pembrolizumab 1palbociclib 1nilotinib 1lorcaserin 1fisetin 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anatomic Stage I Breast Cancer AJCC v8 × Genetic Testing × Clear all
NCT01334021 2026-03-09

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
1,100 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡